TY - JOUR
T1 - Monitoring human-induced pluripotent stem cell-derived cardiomyocytes with genetically encoded calcium and voltage fluorescent reporters
AU - Shinnawi, Rami
AU - Huber, Irit
AU - Maizels, Leonid
AU - Shaheen, Naim
AU - Gepstein, Amira
AU - Arbel, Gil
AU - Tijsen, Anke J.
AU - Gepstein, Lior
N1 - Publisher Copyright:
© 2015 The Authors.
PY - 2015/10/13
Y1 - 2015/10/13
N2 - The advent of the human-induced pluripotent stem cell (hiPSC) technology has transformed biomedical research, providing new tools for human disease modeling, drug development, and regenerative medicine. To fulfill its unique potential in the cardiovascular field, efficient methods should be developed for high-resolution, large-scale, long-term, and serial functional cellular phenotyping of hiPSC-derived cardiomyocytes (hiPSC-CMs). To achieve this goal, we combined the hiPSC technology with genetically encoded voltage (ArcLight) and calcium (GCaMP5G) fluorescent indicators. Expression of ArcLight and GCaMP5G in hiPSC-CMs permitted to reliably follow changes in transmembrane potential and intracellular calcium levels, respectively. This allowed monitoring short- and long-term changes in action-potential and calcium-handling properties and the development of arrhythmias in response to several pharmaceutical agents and in hiPSC-CMs derived from patients with different inherited arrhythmogenic syndromes. Combining genetically encoded fluorescent reporters with hiPSC-CMs may bring a unique value to the study of inherited disorders, developmental biology, and drug development and testing.
AB - The advent of the human-induced pluripotent stem cell (hiPSC) technology has transformed biomedical research, providing new tools for human disease modeling, drug development, and regenerative medicine. To fulfill its unique potential in the cardiovascular field, efficient methods should be developed for high-resolution, large-scale, long-term, and serial functional cellular phenotyping of hiPSC-derived cardiomyocytes (hiPSC-CMs). To achieve this goal, we combined the hiPSC technology with genetically encoded voltage (ArcLight) and calcium (GCaMP5G) fluorescent indicators. Expression of ArcLight and GCaMP5G in hiPSC-CMs permitted to reliably follow changes in transmembrane potential and intracellular calcium levels, respectively. This allowed monitoring short- and long-term changes in action-potential and calcium-handling properties and the development of arrhythmias in response to several pharmaceutical agents and in hiPSC-CMs derived from patients with different inherited arrhythmogenic syndromes. Combining genetically encoded fluorescent reporters with hiPSC-CMs may bring a unique value to the study of inherited disorders, developmental biology, and drug development and testing.
UR - http://www.scopus.com/inward/record.url?scp=84944441603&partnerID=8YFLogxK
U2 - 10.1016/j.stemcr.2015.08.009
DO - 10.1016/j.stemcr.2015.08.009
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26372632
AN - SCOPUS:84944441603
SN - 2213-6711
VL - 5
SP - 582
EP - 596
JO - Stem Cell Reports
JF - Stem Cell Reports
IS - 4
ER -